Efficacy and safety of Saireito (TJ-114) in patients with atrial fibrillation undergoing catheter ablation procedures: A randomized pilot study.

PLoS One · 2024 · PMC11293677 · PMID 39088481

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Conclusions Thirty-day use of Saireito following catheter ablation for AF showed a trend toward reduced atrial tachyarrhythmias during the treatment period.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.